MARATTO

article · The Natural Products Journal

Recent Updates on Chemo Biodiversity of the Genus Cladosporium

Abstract

Endophytes are an appealing source of natural products with unique structures that can aid in the treatment of life-altering disorders because of the complexity and structural variety of the secondary metabolites they produce. The genus <i>Cladosporium</i>, which belongs to family Cladosporiaceae, class Dothideomycetes has received more attention due to the isolation of various classes of compounds with unique structures mainly alkaloids, azaphilones, benzofluoranthenones, coumarins, isocumarins, lactones, naphthalenones, macrolides, perylenequinones and steroids that exhibited diverse biological activities as: Antiviral, antimicrobial, anti-inflammatory, antidiabetic, phytotoxicity and anti-Alzheimer, whereas anticancer compounds predominated. This review focuses on the isolated secondary metabolites from genus Cladosporium specifically, <i>C. cladosporioides, C. sphaerospermum, C. herbarum, C. halotolerans, C. tenuissimum, C. oxyspormum, C. perangustum, C. uredinicola, C. colocasiae, C. delicatulum</i> and <i>C. phlei</i> due to their exquisite bioactivity, the source of the strains, the culture media, the biological potential of isolated secondary metabolites and covers the literature from 2000 to 2023.

Research topics

  • Microbial Community Ecology and Physiology
  • Diatoms and Algae Research
  • Plant Pathogens and Fungal Diseases

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2174/0122103155328257241021033118

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.